Delivery Order SPE2DB20D7059-SPE2DB25FQLC3

Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,051.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,138,140 units of Atropine 1 mg/ml vials, with a performance period extending through May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is a delivery order (SPE2DX15D1120|SPE2DX25FCHLL) with a ceiling value of $1,578.78 for the delivery of Atropine 8 mg/20 ml vials. The contract is not set aside and is a firm fixed price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,714.61, is a delivery order for Atropine 1 mg/ml vials. The contract has a firm fixed price pricing type and an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of ATROPINE 0.4 MG/ML VIALML. The $1,333.35 firm fixed price delivery order contract has a period of performance through July 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $3,027.29, is for the delivery of Atropine 1 mg/ml vials to support various government agencies and healthcare programs. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award is for the delivery of Atropine 1 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The $1,297.41 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024. The contract has an ultimate completion date of November 1, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,346.08 and is for the delivery of ATROPINE 1 MG/ML VIAL. The contract is a Firm Fixed Price, non-set-aside contract with a performance period extending through May 30, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.12 firm fixed-price delivery order is for the supply of ATROPINE 1 MG/ML VIALML, a critical medical product, with a completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,887.72 firm fixed-price delivery order is for the supply of Atropine 1 mg/ml vials, a medication used for various medical purposes. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,983.90 for the supply of ATROPINE 8 MG/20 ML VIAL 20ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 9, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQLC3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a delivery order with a ceiling value of $3,007.97. The contract is a firm fixed-price agreement for the supply of Atropine 1 mg/ml vial. The contract is funded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support to the U.S. military.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This delivery order is likely a task order placed under the broader IDC, enabling the company to supply a range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 10/12/25, 1:07 AM